Breaking News
0

Pharma Mar SAU (PMRG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.865 -0.019    -1.01%
20/09 - Closed. Currency in EUR ( Disclaimer )
Type: Equity
Market: Germany
ISIN: ES0169501030 
S/N: A1423S
  • Volume: 0
  • Bid/Ask: 1.829 / 1.882
  • Day's Range: 1.865 - 1.865
Pharma Mar 1.865 -0.019 -1.01%

PMRG Overview

 
This is the main Pharma Mar SAU stock chart and current price. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close1.884
Day's Range1.865 - 1.865
RevenueN/A
Open1.865
52 wk Range0.912 - 2.43
EPSN/A
VolumeN/A
Market Cap411.13M
Dividend (Yield)N/A (N/A)
Average Vol. (3m)1,136
P/E RatioN/A
BetaN/A
1-Year Change19.25%
Shares OutstandingN/A
Next Earnings DateOct 28, 2019
What is your sentiment on Pharma Mar SAU?
or
Market is currently closed. Voting is open during market hours.

Pharma Mar SAU Analysis


Edison
Pharma Mar: Full Year 2017 Results   By Edison - Mar 14, 2018

Pharma Mar SAU (LON:0RC6) recently reported financial results for 2017. Sales for the year were down 0.9% to €162.6m compared to 2016. Yondelis sales fell 4.1% to €84.6m,...

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Sell Sell Sell Buy
Technical Indicators Sell Sell Sell Sell Strong Buy
Summary Sell Sell Sell Sell Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Completed Patterns
Three Black Crows 1W 1 Sep 08, 2019
Tri-Star Bullish 15 1 Sep 19, 2019 02:00AM
Engulfing Bearish 1M 3 Jun 19
Upside Gap Three Methods 1M 3 Jun 19
Bullish Engulfing 1W 6 Aug 04, 2019

Pharma Mar SAU Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  Madrid 1.858 1.830 1.900 703,512 -1.28% EUR 20/09  
  London 1.84 0.00 0.00 5,041 -3.39% EUR 20/09  
  Frankfurt 1.865 1.829 1.882 0 -1.01% EUR 20/09  
  Berlin 1.829 0.000 0.000 0 -1.93% EUR 20/09  
  Stuttgart 1.829 2.178 2.220 0 0.00% EUR 20/09  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 217.73 222.56 217.47 -3.23 -1.46% 57.98M 20/09  
  Facebook 189.93 193.10 188.12 -0.21 -0.11% 20.36M 20/09  
  Alphabet A 1,229.84 1,242.80 1,223.58 -8.91 -0.72% 1.94M 20/09  
  Amazon.com 1,794.16 1,830.63 1,780.92 -27.34 -1.50% 5.56M 20/09  
  Tesla 240.62 246.95 238.16 -5.98 -2.42% 6.51M 20/09  
  Netflix 270.75 282.50 266.00 -15.85 -5.53% 23.95M 20/09  
  Microsoft 139.44 141.65 138.25 -1.63 -1.16% 40.04M 20/09  
  IBM 141.88 143.83 141.82 -1.09 -0.76% 5.22M 20/09  
  Boeing 379.39 384.73 377.92 -5.05 -1.31% 6.85M 20/09  
  Goldman Sachs 213.74 216.68 213.63 -1.49 -0.69% 5.49M 20/09  

Pharma Mar SAU Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

440

Equity Type

ORD

Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and immunomodulation, as well as tropical diseases areas. It manufactures and sells Yondelis, a synthetically modified antitumor agent, which is derived from sea squirts and is implemented in the treatment of soft tissue sarcomas and relapsed ovarian cancer. Furthermore, the Company's products pipeline comprises drug candidates and agents for cancer treatment, such as Aplidin, PM01183 and PM060184. The Company operates through subsidiaries in Italy, Germany, France, and the United States, among others.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $500 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PHMR Comments

Write your thoughts about Pharma Mar SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email